GFAT overexpression has been observed in prostate cancer biopsies before91, and its activity appears to be associated with postprandial hyperglycemia in DM2 patients.23 In summary, our data suggest that HBP may be altering the tumor cell biology and accelerating the malignancy process through aberrant glycosylation. This evidence concerns the gene GFPT2 and prostate cancer.